Importance is a model-assigned 1–5 on published stories, not a market forecast.
Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.
An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.
Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.
Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.
A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.
Ahead
scheduled · today and tomorrow · calendar refreshed 2026-10-12
07:50 Google News: China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group (03320.HK): Kunming Pharmaceutical Group forecasts a net loss attributable to shareholders of RMB 330 million to RMB 400 million for the first half of the year, swinging from profit to loss
Kunming Pharmaceutical Group, part of China Resources Pharmaceutical, forecast a first-half net loss of RMB 330-400 million, swinging from a prior-year profit.
SNT Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients
SNT Biotech announced a partnership with Waters Corporation to bring an FDA-cleared at-home HPV cervical cancer screening tool to patients.